Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
9.75
+0.11 (1.14%)
At close: Aug 26, 2026, 4:00 PM EDT
9.75
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:41 PM EDT
Orthofix Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 833.19 | 822.31 | 799.49 | 746.64 | 460.71 | 464.48 | |
Revenue Growth | 2.99% | 2.85% | 7.08% | 62.06% | -0.81% | 14.25% |
Cost of Revenue | 239.46 | 245.43 | 241.42 | 224.32 | 123.54 | 114.91 |
Gross Profit | 593.73 | 576.88 | 558.07 | 522.32 | 337.17 | 349.57 |
Selling, General & Admin | 557.7 | 554.33 | 532.53 | 530.4 | 308.78 | 290.67 |
Research & Development | 61.41 | 65.85 | 73.64 | 80.23 | 49.07 | 49.62 |
Amortization of Goodwill & Intangibles | 12.18 | 14.31 | 17.44 | 17.46 | 9.8 | 9.41 |
Operating Expenses | 631.29 | 634.49 | 623.6 | 628.08 | 367.64 | 349.7 |
Operating Income | -37.56 | -57.61 | -65.53 | -105.77 | -30.47 | -0.13 |
Interest Expense | -20.78 | -17.49 | -29.63 | -8.63 | -1.29 | -1.84 |
Currency Exchange Gain (Loss) | -5.44 | - | -0.63 | - | -3.29 | -3.98 |
Other Non Operating Income (Expenses) | 5.06 | 8.11 | -3.22 | -0.94 | 0.32 | 0.33 |
EBT Excluding Unusual Items | -58.72 | -66.99 | -99.01 | -115.34 | -34.72 | -5.62 |
Merger & Restructuring Charges | 0.39 | -24.96 | -12.19 | -36.04 | - | - |
Impairment of Goodwill | - | - | - | - | - | -11.76 |
Gain (Loss) on Sale of Investments | - | - | -5.78 | - | -0.18 | 0.31 |
Legal Settlements | -0.1 | - | - | - | - | - |
Other Unusual Items | -1.85 | 1.14 | -6.9 | 2.7 | 17.2 | 3.58 |
Pretax Income | -60.29 | -90.81 | -123.88 | -148.68 | -17.71 | -13.5 |
Income Tax Expense | 1.44 | 1.38 | 2.12 | 2.72 | 2.04 | 24.88 |
Earnings From Continuing Operations | -61.72 | -92.19 | -126 | -151.4 | -19.75 | -38.38 |
Net Income | -61.72 | -92.19 | -126 | -151.4 | -19.75 | -38.38 |
Net Income to Common | -61.72 | -92.19 | -126 | -151.4 | -19.75 | -38.38 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 40 | 40 | 38 | 37 | 20 | 20 |
Shares Outstanding (Diluted) | 40 | 40 | 38 | 37 | 20 | 20 |
Shares Change | 3.56% | 3.85% | 3.82% | 83.16% | 1.84% | 1.54% |
EPS (Basic) | -1.53 | -2.33 | -3.30 | -4.12 | -0.98 | -1.95 |
EPS (Diluted) | -1.53 | -2.33 | -3.30 | -4.12 | -0.98 | -1.95 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -27.82 | -1.28 | -9.09 | -107.8 | -34.7 | 0.69 |
Free Cash Flow Per Share | -0.69 | -0.03 | -0.24 | -2.94 | -1.73 | 0.04 |
Gross Margin | 71.26% | 70.15% | 69.80% | 69.96% | 73.18% | 75.26% |
Operating Margin | -4.51% | -7.01% | -8.20% | -14.17% | -6.61% | -0.03% |
Profit Margin | -7.41% | -11.21% | -15.76% | -20.28% | -4.29% | -8.26% |
Free Cash Flow Margin | -3.34% | -0.16% | -1.14% | -14.44% | -7.53% | 0.15% |
EBITDA | 20.93 | 4.72 | 10.43 | -45.21 | 1.61 | 32.96 |
EBITDA Margin | 2.51% | 0.57% | 1.31% | -6.05% | 0.35% | 7.10% |
D&A For EBITDA | 58.49 | 62.32 | 75.96 | 60.56 | 32.08 | 33.1 |
EBIT | -37.56 | -57.61 | -65.53 | -105.77 | -30.47 | -0.13 |
EBIT Margin | -4.51% | -7.01% | -8.20% | -14.16% | -6.61% | -0.03% |
Advertising Expenses | - | - | - | - | - | 0.5 |